Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Since it mimics both GLP-1 and GIP, it may be more effective than semaglutide
It is the difference between usable material and expensive waste
One study demonstrated that exendin-4 (50 nM) treatment reduces the expression of pro-inflammatory genes such as NF-B p65 and the TNF receptor superfamily member 1A in human pancreatic islet cells (Velmurugan et al., 2012)
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
For tirzepatide users on Mounjaro or Zepbound, you have slightly more flexibility between the stomach and thigh, but the abdomen generally delivers the most consistent results during early dose escalations
The muscle-wasting effects have prompted scientists to try to find a drug to counteract them
